Abstract
Although there has been a growing body of literature about bisphosphonates since 1969, it was not until 2003 that treatment with this medication was associated with osteonecrosis of the jaw. Presented herein is such a case.
MeSH terms
-
Bisphosphonate-Associated Osteonecrosis of the Jaw / pathology*
-
Diphosphonates / administration & dosage
-
Diphosphonates / adverse effects*
-
Female
-
Humans
-
Middle Aged
-
Osteoporosis / drug therapy*
-
Osteoporosis / pathology*